Seminar on approach to
schizophrenia
Moderator –Dr ABDI B.(MD,Assistant Prof.of Psychiatry)
Presenter –Dr FIRAOL G.(MD,IMR-I)
OUTLINE
• Introduction
• Definition
• Clinical diagnosis
• Management principles
Introduction
• Schizophrenia is among the most disabling and economically catastrophic
medical disorders.
• It is ranked by the World Health Organization as one of the top 10 illnesses
contributing to the global burden of disease
Cont…
• The prevalence of schizophrenia approaches 1 percent internationally.
• The incidence is about 1.5 per 10,000 people .
• Age of onset is typically during adolescence
• childhood and late-life onset (over 45 years) are less common.
• Slightly more men are diagnosed with schizophrenia than women (1.4:1)
and women tend to be diagnosed later in life than men
Definition
• Chronic, sever, debilitating mental illness.
• It is characterized by symptoms of thought, behaviour, and functional
problems
Clinical manifestations
• Schizophrenia is a syndrome.
• Individuals with schizophrenia generally present with several symptoms
-Positive symptoms
-Negative symptoms
- Cognitive impairment
-Mood and anxiety symptoms
• Positive symptoms —
-This group of symptoms includes the reality distortion symptoms of hallucinations and
delusions, as well as disorganized thoughts and behavior
Hallucinations — Hallucinations are defined as the perception of a sensory process in the
absence of an external source.
-They can be auditory, visual, somatic, olfactory, or gustatory
-Auditory hallucinations are the most common form of hallucination, with prevalence
estimates between 40 and 80 percent in people with schizophrenia
• Delusions — Delusions are defined as a fixed, false belief and are present
in approximately 80 percent of people with schizophrenia
• Delusions are broadly categorized as bizarre or nonbizarre
-Bizarre delusions are clearly implausible (ie, they have no possibility of
being true
- A nonbizarre delusion is one that while not true is understandable and has
the possibility of being true.
• Disorganization — People with schizophrenia typically display some
disorganization in behavior or thinking
• The symptoms of disorganization are -
-Tangential speech – The person gets increasingly further off the topic without
appropriately answering a question.
-Circumstantial speech – The person will eventually answer a question, but in a
markedly round about manner.
-Derailment – The person suddenly switches topic without any logic
-Neologisms – The creation of new, idiosyncratic words.
-Word salad – Words are thrown together without any sensible meaning.
• Negative symptoms — Negative symptoms are usually one of the first
manifestations of schizophrenia.
• up to 70 percent of patients experience negative symptoms prior to their
first positive symptom
Abnormal motor activity
Extreme motor agitation or retardation
Stereotyped behaviors
Waxy flexibility
Stupor
Negativism
Ecopraxia
Cognitive symptoms
• Inattention, easily distracted
• Impaired memory
• Poor problem-solving skills
• Poor decision-making skills
• Illogical thinking
• Impaired judgment
• Impaired learning
Mood and anxiety symptoms
• Depressed mood
• Anxious mood
• Guilty feeling
• Irritability
• Worry and tension
25-30% of schizophrenics develop depression in any phase of the
illness.
Functional impairment
• Decreased ability to work
• Problem in interpersonal relationships
• Poor self care
• Social functioning
Outcome of schizophrenia
Devastating illness
>50% of patients- long-term incapacity
>10% of patients commit suicide
Bad prognostic signs
Insidious onset
Long duration of episode
Childhood behavioral problems
Family history of schizophrenia
Unmarried, male
Low social class
Etiology
• Multifactorial causation
• Biologic,
• Non-biologic
• 1. BIOLOGIC
• Genetic
• Biochemical Factors
• Structural changes
• Physiological changes
• Psychoneuroendocrinology/immunology
Genetic -Twin studies-Adoption studies - Family studies
Prevalence of Schizophrenia in Specific Populations
Population Prevalence (%)
General population 1
Non-twin sibling of a schizophrenia patient 8
Child with one parent with schizophrenia 12
Dizygotic twin of a schizophrenia patient 12
Child of two parents with schizophrenia 40
Monozygotic twin of a schizophrenia patient 47
Biochemical Factors
Dopamine Hypothesis
Schizophrenia results from too much dopaminergic activity
Revised Dopamine hypothesis – increased dopamine at mesolimbic,
and decreased dopamine at mesocortical pathway
Other neurtransmitters- Glutamate, GABA, Serotonine, norepinephrine,
neuropeptides
Structural changes
Neuropathological basis for schizophrenia,
• Lateral and third ventricular enlargement
• Some reduction in cortical volume
• Reduced symmetry in schizophrenia
• the temporal, frontal, and occipital lobes
Physiological changes
• EEG
• Evoked Potentials
• Magnetic resonance spectroscopy- decreased brain metabolism
Psychoneuroimmunology - Immunological abnormalities
Psychoneuroendocrinology
 Hormonal abnormality- hypothalamic-pitutary axis
Non biologic causes
Psychoanalytic Theories
 Schizophrenia resulted from developmental fixations that occurred
earlier
odefects in ego development
Affects Interpretation of reality and the control of inner drives(sex and aggression)
oA disturbance in interpersonal relatedness
Learning Theories
 poor models for learning during childhood
learn irrational reactions and ways of thinking by imitating parents
Family Dynamics
 A poor mother-child relationship - increase in the risk of developing
schizophrenia
 A specific family pattern plays a causative role in the development of
schizophrenia
Pathological family behavior that can significantly increase the emotional stress
Psychosocial
 Low social class
 Immigration
 Social isolation
DIAGNOSIS
Psychosis is first and foremost a diagnosis of exclusion
• Relevant and known causes of psychosis should be ruled out before
diagnosing primary psychiatric disorders
• A comprehensive history
• Physical examination
• Neurological examination
Excluding medical illnesses
Blood tests
• TSH -exclude hypo or hyperthyroidism,
• Basic electrolytes and serum calcium to rule out a metabolic disturbance
• OFT
• CBC including ESR to rule out a systemic infection or chronic disease
• Blood film; titers of thyphoid/typhus
• Serology to exclude syphilis or HIV infection
Other investigations include:
• EEG to exclude epilepsy
• MRI or CT scan of the head to exclude brain lesions
Substance/ medication screening – urinalysis, serum toxicology- as indicated
MANAGEMENT
The treatment of psychosis depends on the specific diagnosis
1. Treating primary condition- medical illness/ substance use disorder/primary
psychiatric disorder
2. Antipsychotic medications
• The first line psychiatric treatment for many psychotic disorders is
antipsychotic medications
• Can reduce the positive symptoms of psychosis
3. Adjunctive drugs
4. ECT
Hospitalization- is indicated for
• diagnostic purposes
• for stabilization of medications
• for patients' safety because of suicidal or humicidal
ideation
• for grossly disorganized or inappropriate behaviour
• Short stays of 4 to 6 weeks are just as effective as long-term
hospitalizations
ACUTE TREATMENT
The goal is immediate control of psychosis.
Treatment principles for to treat someone with first episode of
schizophrenia
- start treatment as soon as possible
-decrease stress and other risk factors
-start with low dose and titrate to initial dose range.
-best use Second generation antipsychotics, if possible
Pharmacological treatment be initiated promptly
Antipsychotic medications- selection guided by
• the patient’s previous experience with antipsychotics
Adjunctive medications
• Benzodiazepines may be used to treat catatonia, anxiety and agitation
• Antidepressants -for treating co-morbid major depression
• Mood stabilizers and beta-blockers may be used for reducing the severity of
recurrent hostility and aggression
Psychosocial interventions - Reducing over stimulating or stressful relationships,
environments
–The dose may be titrated as quickly as tolerated to the target
therapeutic dose of the antipsychotic medication
• Monitoring of the patient’s clinical status for 2–4 weeks
• Avoid the temptation to prematurely escalate the dose for patients
who are responding slowly
II-Stabilization phase
• Goals - to enhance the patient’s adaptation to life
• Premature lowering of dose or discontinuation of medication during
this phase may lead to a recurrence of symptoms and possible relapse
III-Stable Phase
• Goal- ensure that symptom remission or control is sustained
• Regular monitoring for adverse effects
During the stable phase of treatment - routinely monitor
• Extrapyramidal side effects
• Weight, waist circumference, and BMI
• Blood pressure
• Symptoms of diabetes- Fasting glucose
• Evaluate whether residual negative symptoms are present or
prominent
• Hematology
• Blood chemistries, lipid abnormalities
Drug discontinuation
• No reliable indicator to differentiate the minority from the majority who will
relapse with drug discontinuation.
• Warn early signs of relapse;
• attend outpatient visits on a regular basis
• Indefinite maintenance antipsychotic medication - patients who have had
multiple prior episodes or two episodes within 5 years
Psychotherapy in Psychosis
Psychosocial treatments during the stable phase.
• Family intervention
• Supported employment
• Assertive community treatment,
• skills training, and
• cognitive behaviorally oriented psychotherapy
REFERENCES
• Kaplan and Sadock’s, Synopsis of Psychiatry 11th edition
• ONLINE UPTODATE
THANK YOU

Seminar on approach to schizophrenia.pptx

  • 1.
    Seminar on approachto schizophrenia Moderator –Dr ABDI B.(MD,Assistant Prof.of Psychiatry) Presenter –Dr FIRAOL G.(MD,IMR-I)
  • 2.
    OUTLINE • Introduction • Definition •Clinical diagnosis • Management principles
  • 3.
    Introduction • Schizophrenia isamong the most disabling and economically catastrophic medical disorders. • It is ranked by the World Health Organization as one of the top 10 illnesses contributing to the global burden of disease
  • 4.
    Cont… • The prevalenceof schizophrenia approaches 1 percent internationally. • The incidence is about 1.5 per 10,000 people . • Age of onset is typically during adolescence • childhood and late-life onset (over 45 years) are less common. • Slightly more men are diagnosed with schizophrenia than women (1.4:1) and women tend to be diagnosed later in life than men
  • 5.
    Definition • Chronic, sever,debilitating mental illness. • It is characterized by symptoms of thought, behaviour, and functional problems
  • 6.
    Clinical manifestations • Schizophreniais a syndrome. • Individuals with schizophrenia generally present with several symptoms -Positive symptoms -Negative symptoms - Cognitive impairment -Mood and anxiety symptoms
  • 7.
    • Positive symptoms— -This group of symptoms includes the reality distortion symptoms of hallucinations and delusions, as well as disorganized thoughts and behavior Hallucinations — Hallucinations are defined as the perception of a sensory process in the absence of an external source. -They can be auditory, visual, somatic, olfactory, or gustatory -Auditory hallucinations are the most common form of hallucination, with prevalence estimates between 40 and 80 percent in people with schizophrenia
  • 8.
    • Delusions —Delusions are defined as a fixed, false belief and are present in approximately 80 percent of people with schizophrenia • Delusions are broadly categorized as bizarre or nonbizarre -Bizarre delusions are clearly implausible (ie, they have no possibility of being true - A nonbizarre delusion is one that while not true is understandable and has the possibility of being true.
  • 9.
    • Disorganization —People with schizophrenia typically display some disorganization in behavior or thinking • The symptoms of disorganization are - -Tangential speech – The person gets increasingly further off the topic without appropriately answering a question. -Circumstantial speech – The person will eventually answer a question, but in a markedly round about manner. -Derailment – The person suddenly switches topic without any logic -Neologisms – The creation of new, idiosyncratic words. -Word salad – Words are thrown together without any sensible meaning.
  • 10.
    • Negative symptoms— Negative symptoms are usually one of the first manifestations of schizophrenia. • up to 70 percent of patients experience negative symptoms prior to their first positive symptom
  • 12.
    Abnormal motor activity Extrememotor agitation or retardation Stereotyped behaviors Waxy flexibility Stupor Negativism Ecopraxia
  • 13.
    Cognitive symptoms • Inattention,easily distracted • Impaired memory • Poor problem-solving skills • Poor decision-making skills • Illogical thinking • Impaired judgment • Impaired learning
  • 14.
    Mood and anxietysymptoms • Depressed mood • Anxious mood • Guilty feeling • Irritability • Worry and tension 25-30% of schizophrenics develop depression in any phase of the illness.
  • 15.
    Functional impairment • Decreasedability to work • Problem in interpersonal relationships • Poor self care • Social functioning
  • 18.
    Outcome of schizophrenia Devastatingillness >50% of patients- long-term incapacity >10% of patients commit suicide Bad prognostic signs Insidious onset Long duration of episode Childhood behavioral problems Family history of schizophrenia Unmarried, male Low social class
  • 19.
    Etiology • Multifactorial causation •Biologic, • Non-biologic • 1. BIOLOGIC • Genetic • Biochemical Factors • Structural changes • Physiological changes • Psychoneuroendocrinology/immunology
  • 20.
    Genetic -Twin studies-Adoptionstudies - Family studies Prevalence of Schizophrenia in Specific Populations Population Prevalence (%) General population 1 Non-twin sibling of a schizophrenia patient 8 Child with one parent with schizophrenia 12 Dizygotic twin of a schizophrenia patient 12 Child of two parents with schizophrenia 40 Monozygotic twin of a schizophrenia patient 47
  • 21.
    Biochemical Factors Dopamine Hypothesis Schizophreniaresults from too much dopaminergic activity Revised Dopamine hypothesis – increased dopamine at mesolimbic, and decreased dopamine at mesocortical pathway Other neurtransmitters- Glutamate, GABA, Serotonine, norepinephrine, neuropeptides
  • 22.
    Structural changes Neuropathological basisfor schizophrenia, • Lateral and third ventricular enlargement • Some reduction in cortical volume • Reduced symmetry in schizophrenia • the temporal, frontal, and occipital lobes
  • 23.
    Physiological changes • EEG •Evoked Potentials • Magnetic resonance spectroscopy- decreased brain metabolism Psychoneuroimmunology - Immunological abnormalities Psychoneuroendocrinology  Hormonal abnormality- hypothalamic-pitutary axis
  • 24.
    Non biologic causes PsychoanalyticTheories  Schizophrenia resulted from developmental fixations that occurred earlier odefects in ego development Affects Interpretation of reality and the control of inner drives(sex and aggression) oA disturbance in interpersonal relatedness Learning Theories  poor models for learning during childhood learn irrational reactions and ways of thinking by imitating parents
  • 25.
    Family Dynamics  Apoor mother-child relationship - increase in the risk of developing schizophrenia  A specific family pattern plays a causative role in the development of schizophrenia Pathological family behavior that can significantly increase the emotional stress Psychosocial  Low social class  Immigration  Social isolation
  • 26.
    DIAGNOSIS Psychosis is firstand foremost a diagnosis of exclusion • Relevant and known causes of psychosis should be ruled out before diagnosing primary psychiatric disorders • A comprehensive history • Physical examination • Neurological examination
  • 27.
    Excluding medical illnesses Bloodtests • TSH -exclude hypo or hyperthyroidism, • Basic electrolytes and serum calcium to rule out a metabolic disturbance • OFT • CBC including ESR to rule out a systemic infection or chronic disease • Blood film; titers of thyphoid/typhus • Serology to exclude syphilis or HIV infection Other investigations include: • EEG to exclude epilepsy • MRI or CT scan of the head to exclude brain lesions Substance/ medication screening – urinalysis, serum toxicology- as indicated
  • 28.
    MANAGEMENT The treatment ofpsychosis depends on the specific diagnosis 1. Treating primary condition- medical illness/ substance use disorder/primary psychiatric disorder 2. Antipsychotic medications • The first line psychiatric treatment for many psychotic disorders is antipsychotic medications • Can reduce the positive symptoms of psychosis 3. Adjunctive drugs 4. ECT
  • 29.
    Hospitalization- is indicatedfor • diagnostic purposes • for stabilization of medications • for patients' safety because of suicidal or humicidal ideation • for grossly disorganized or inappropriate behaviour • Short stays of 4 to 6 weeks are just as effective as long-term hospitalizations
  • 30.
    ACUTE TREATMENT The goalis immediate control of psychosis. Treatment principles for to treat someone with first episode of schizophrenia - start treatment as soon as possible -decrease stress and other risk factors -start with low dose and titrate to initial dose range. -best use Second generation antipsychotics, if possible
  • 31.
    Pharmacological treatment beinitiated promptly Antipsychotic medications- selection guided by • the patient’s previous experience with antipsychotics Adjunctive medications • Benzodiazepines may be used to treat catatonia, anxiety and agitation • Antidepressants -for treating co-morbid major depression • Mood stabilizers and beta-blockers may be used for reducing the severity of recurrent hostility and aggression Psychosocial interventions - Reducing over stimulating or stressful relationships, environments
  • 32.
    –The dose maybe titrated as quickly as tolerated to the target therapeutic dose of the antipsychotic medication • Monitoring of the patient’s clinical status for 2–4 weeks • Avoid the temptation to prematurely escalate the dose for patients who are responding slowly
  • 33.
    II-Stabilization phase • Goals- to enhance the patient’s adaptation to life • Premature lowering of dose or discontinuation of medication during this phase may lead to a recurrence of symptoms and possible relapse III-Stable Phase • Goal- ensure that symptom remission or control is sustained • Regular monitoring for adverse effects
  • 34.
    During the stablephase of treatment - routinely monitor • Extrapyramidal side effects • Weight, waist circumference, and BMI • Blood pressure • Symptoms of diabetes- Fasting glucose • Evaluate whether residual negative symptoms are present or prominent • Hematology • Blood chemistries, lipid abnormalities
  • 35.
    Drug discontinuation • Noreliable indicator to differentiate the minority from the majority who will relapse with drug discontinuation. • Warn early signs of relapse; • attend outpatient visits on a regular basis • Indefinite maintenance antipsychotic medication - patients who have had multiple prior episodes or two episodes within 5 years
  • 36.
    Psychotherapy in Psychosis Psychosocialtreatments during the stable phase. • Family intervention • Supported employment • Assertive community treatment, • skills training, and • cognitive behaviorally oriented psychotherapy
  • 37.
    REFERENCES • Kaplan andSadock’s, Synopsis of Psychiatry 11th edition • ONLINE UPTODATE
  • 38.

Editor's Notes

  • #33 Monotherapy –”start low-go slow”